Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manhui Zhu

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Experimental Cell Research|January 8, 2026
Fetuin B drives metabolism-associated steatohepatitis by promoting hepatocyte pyroptosis via NLRP3/GSDMD pathwayShi Chen, Yue Wang, Jingwen Gao, et al.
Frontiers in Pharmacology|April 8, 2026
Gypenoside XLIX ameliorates diabetic retinopathy by downregulating prostaglandin-endoperoxide synthase 2 in retinal pigment epithelium cells to inhibit ferroptosis and preserve tight junction integrityJiayi Gu, Manhui Zhu, Lele Li, et al.
Biochemical and Biophysical Research Communications|August 18, 2020
PG545 alleviates diabetic retinopathy by promoting retinal Müller cell autophagy to inhibit the inflammatory responseYing Wang, Xiaojuan Liu, Linling Zhu, et al.
Experimental Eye Research|August 23, 2024
CBX7 promotes choroidal neovascularization by activating the HIF-1α/VEGF pathway in choroidal vascular endothelial cellsQiaoyun Wang, Manhui Zhu, Wendie Li, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 31, 2021
Melatonin attenuates oxidative stress and inflammation of Müller cells in diabetic retinopathy via activating the Sirt1 pathwayYuanyuan Tu, E Song, Zhenzhen Wang, et al.
Science Advances|July 11, 2025
Dynamically covalent lipid nanoparticles mediate CRISPR-Cas9 genome editing against choroidal neovascularization in miceDesheng Cao, Junliang Zhu, Yang Guo, et al.
ACS Nano|May 26, 2021
Targeted Noninvasive Treatment of Choroidal Neovascularization by Hybrid Cell-Membrane-Cloaked Biomimetic NanoparticlesManjing Li, Zhaojian Xu, Lu Zhang, et al.
Journal of Cellular Physiology|July 5, 2019
Brivanib, a multitargeted small-molecule tyrosine kinase inhibitor, suppresses laser-induced CNV in a mouse model of neovascular AMDLele Li, Manhui Zhu, Wenli Wu, et al.
Journal of Cellular Physiology|April 24, 2020
Melatonin inhibits Müller cell activation and pro-inflammatory cytokine production via upregulating the MEG3/miR-204/Sirt1 axis in experimental diabetic retinopathyYuanyuan Tu, Manhui Zhu, Zhenzhen Wang, et al.
Advanced Materials (Deerfield Beach, Fla.)|December 24, 2024
Rationally Engineering Pro-Proteins and Membrane-Penetrating α‑Helical Polypeptides for Genome Editing Toward Choroidal Neovascularization TreatmentXun Liu, Ziyin Zhao, Wei Li, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Experimental Cell Research|January 8, 2026
Fetuin B drives metabolism-associated steatohepatitis by promoting hepatocyte pyroptosis via NLRP3/GSDMD pathwayShi Chen, Yue Wang, Jingwen Gao, et al.
Frontiers in Pharmacology|April 8, 2026
Gypenoside XLIX ameliorates diabetic retinopathy by downregulating prostaglandin-endoperoxide synthase 2 in retinal pigment epithelium cells to inhibit ferroptosis and preserve tight junction integrityJiayi Gu, Manhui Zhu, Lele Li, et al.
Biochemical and Biophysical Research Communications|August 18, 2020
PG545 alleviates diabetic retinopathy by promoting retinal Müller cell autophagy to inhibit the inflammatory responseYing Wang, Xiaojuan Liu, Linling Zhu, et al.
Experimental Eye Research|August 23, 2024
CBX7 promotes choroidal neovascularization by activating the HIF-1α/VEGF pathway in choroidal vascular endothelial cellsQiaoyun Wang, Manhui Zhu, Wendie Li, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 31, 2021
Melatonin attenuates oxidative stress and inflammation of Müller cells in diabetic retinopathy via activating the Sirt1 pathwayYuanyuan Tu, E Song, Zhenzhen Wang, et al.
Science Advances|July 11, 2025
Dynamically covalent lipid nanoparticles mediate CRISPR-Cas9 genome editing against choroidal neovascularization in miceDesheng Cao, Junliang Zhu, Yang Guo, et al.
ACS Nano|May 26, 2021
Targeted Noninvasive Treatment of Choroidal Neovascularization by Hybrid Cell-Membrane-Cloaked Biomimetic NanoparticlesManjing Li, Zhaojian Xu, Lu Zhang, et al.
Journal of Cellular Physiology|July 5, 2019
Brivanib, a multitargeted small-molecule tyrosine kinase inhibitor, suppresses laser-induced CNV in a mouse model of neovascular AMDLele Li, Manhui Zhu, Wenli Wu, et al.
Journal of Cellular Physiology|April 24, 2020
Melatonin inhibits Müller cell activation and pro-inflammatory cytokine production via upregulating the MEG3/miR-204/Sirt1 axis in experimental diabetic retinopathyYuanyuan Tu, Manhui Zhu, Zhenzhen Wang, et al.
Advanced Materials (Deerfield Beach, Fla.)|December 24, 2024
Rationally Engineering Pro-Proteins and Membrane-Penetrating α‑Helical Polypeptides for Genome Editing Toward Choroidal Neovascularization TreatmentXun Liu, Ziyin Zhao, Wei Li, et al.
Pageof 6